share_log

OptimizeRx Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results and Issued FY24 Sales Guidance Below Estimates.

OptimizeRx Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results and Issued FY24 Sales Guidance Below Estimates.

優化藥品的股票在公司報告了低於預期的第三季度銷售業績併發布了低於預估的2024財年銷售指引後交易下跌。
Benzinga ·  11/13 16:35
OptimizeRx Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results and Issued FY24 Sales Guidance Below Estimates.
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論